Details 7 Related Guidelines / Approvals

Indicated for the treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.

type

FDA Approval

approval date

2021-08-25

settings
settings
Locally advanced
settings
Metastatic
settings
Subsequent line
source

FDA